Availability of Transgene's 2024 Universal Registration Document (URD)

Transgene (PARIS:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 10, 2025, under number D.25-0243.

This document, available on ...

https://www.benzinga.com/pressreleases/25/04/g44747140/availability-of-transgenes-2024-universal-registration-document-urd